标题
Glutathione S-transferase P1-1 as a target for mesothelioma treatment
作者
关键词
-
出版物
CANCER SCIENCE
Volume 104, Issue 2, Pages 223-230
出版商
Wiley
发表日期
2012-11-05
DOI
10.1111/cas.12061
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy
- (2015) Michela Pasello et al. Analytical Cellular Pathology
- Malignant pleural mesothelioma
- (2012) S. E. Chen et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- New Insights into the Mechanism of JNK1 Inhibition by Glutathione Transferase P1-1
- (2012) Anastasia De Luca et al. BIOCHEMISTRY
- Systemic treatment of malignant pleural mesothelioma
- (2012) Federica Grosso et al. Future Oncology
- The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma
- (2011) Lucio Tentori et al. EUROPEAN JOURNAL OF CANCER
- Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines
- (2011) Andrea Sau et al. Molecular BioSystems
- Malignant pleural mesothelioma: The standard of care and challenges for future management
- (2010) Jan P. van Meerbeeck et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin
- (2010) Anamaria Brozovic et al. CRITICAL REVIEWS IN TOXICOLOGY
- Activated cAMP Response Element Binding Protein Is Overexpressed in Human Mesotheliomas and Inhibits Apoptosis
- (2009) Arti Shukla et al. AMERICAN JOURNAL OF PATHOLOGY
- The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells
- (2009) Alessandro Ascione et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells
- (2009) Yoshitaka Sekido CANCER SCIENCE
- In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma
- (2009) Francesca Pellizzari Tregno et al. EUROPEAN JOURNAL OF CANCER
- Overcoming Resistance to Conventional Drugs in Ewing Sarcoma and Identification of Molecular Predictors of Outcome
- (2009) Katia Scotlandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of caspase-3 activity and activation by protein glutathionylation
- (2008) Zhishan Huang et al. BIOCHEMICAL PHARMACOLOGY
- Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma
- (2008) J B Sørensen et al. BRITISH JOURNAL OF CANCER
- Overcoming Glutathione S-Transferase P1-Related Cisplatin Resistance in Osteosarcoma
- (2008) M. Pasello et al. CANCER RESEARCH
- Enhanced Antitumor Therapy by Inhibition of p21waf1 in Human Malignant Mesothelioma
- (2008) R. Lazzarini et al. CLINICAL CANCER RESEARCH
- Malignant mesothelioma 2008
- (2008) Michael D Zervos et al. CURRENT OPINION IN PULMONARY MEDICINE
- Systemic Treatments for Mesothelioma: Standard and Novel
- (2008) Hedy Lee Kindler CURRENT TREATMENT OPTIONS IN ONCOLOGY
- 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer
- (2008) G. Filomeni et al. MOLECULAR CANCER THERAPEUTICS
- Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin
- (2008) Christina Peklak-Scott et al. MOLECULAR CANCER THERAPEUTICS
- The contribution of c-Jun N-terminal kinase activation and subsequent Bcl-2 phosphorylation to apoptosis induction in human B-cells is dependent on the mode of action of specific stresses
- (2008) Donna E. Muscarella et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started